Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036) [Phase 3]
A Phase 3 trial evaluating pembrolizumab followed by maintenance olaparib with first-line chemotherapy in BRCA non-mutated advanced epitheli…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Study of ESG401 in Adults With Solid Tumors [Phase 1, Phase 2]
Clinical trial update on ESG401 in adults with solid tumors, spanning Phase 1 and Phase 2. The study status is completed.
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating secondary cytoreductive surgery after chemotherapy for recurrent epithelial ovarian cancer is currently …
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer [Phase 3]
Phase III study evaluating BD0801 in combination with chemotherapy for recurrent, platinum-resistant epithelial ovarian cancer has completed…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer . [Phase 2]
Phase 2 trial evaluating pembrolizumab with chemotherapy as neoadjuvant treatment for stage IV ovarian cancer has completed (status: COMPLET…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression
A clinical trial update evaluating the efficacy and safety of sacituzumab govitecan in patients with ovarian clear cell carcinoma after prog…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Identifying Genetic Targets in Gynecological Tumors
An ongoing clinical trial sponsored by Azienda USL Reggio Emilia - IRCCS is recruiting to identify genetic targets in gynecologic tumors, fo…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer [Phase 3]
A Phase 3 trial comparing niraparib alone to niraparib plus bevacizumab in advanced ovarian, fallopian tube, and peritoneal cancers is curre…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial [Phase 3]
Phase 3 randomized, placebo-controlled trial evaluating dietary fiber during radiotherapy in cancer patients has completed.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Genetically Modified T Cells Against Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating genetically modified T cells for ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Clinical Validation of Sophia Genetics Assay
Clinical trial update reporting validation of the Sophia Genetics assay, with NOT_YET_RECRUITING status across ovarian cancer, breast cancer…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial is evaluating first-line treatment with carboplatin plus mirvetuximab soravtansine for advanced-stage ovarian, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study evaluating SYN818 in combination with olaparib for locally advanced or metastatic solid tumors is currently recruiting, includ…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas. [Phase 1]
This ClinicalTrials.gov entry reports a completed Phase 1 study evaluating the safety, tolerability, and preliminary activity of trabectedin…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons
The DETECT study is evaluating tampon-based testing for detection of endometrial cancer, endometrial cancer precursors, and ovarian cancer; …
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Taste Alteration, Sarcopenia, and Malnutrition in Gynecologic Cancer Patients Receiving Carboplatin-Paclitaxel Chemotherapy
A completed clinical trial in gynecologic cancers evaluated taste alteration, sarcopenia, and malnutrition in patients treated with carbopla…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer
The document reports a clinical trial update where exosome-based OCS products are being used for recurrence monitoring after initial treatme…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer [Phase 2]
Phase 2 trial of AL2846 capsules for advanced lung cancer and advanced ovarian cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2025-08-29Clinical Trial Update: MOLecular Characterization and Treatment of THYroid Carcinoma on Struma Ovarii
A clinical trial investigating molecular characterization and treatment of thyroid carcinoma arising in struma ovarii (ovarian cancer) was w…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer [Phase 2]
Phase 2 clinical trial update examining etoposide capsules plus bevacizumab, iparomlimab, and tuvonralimab for platinum-resistant or platinu…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer [Phase 2]
An ongoing Phase 2 trial evaluating the anti-tumor effects of 2X-121 in patients with recurrent, advanced ovarian cancer. Recruitment is ong…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating outcomes after secondary cytoreductive surgery with or without carboplatin-based HIPEC, followed by systemic chemot…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers [Phase 2]
Phase 2 clinical trial update evaluating cryocompression with or without cilostazol to prevent paclitaxel-induced neuropathy in gynecologic …
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Gavo-cel (TC-210), a mesothelin-targeted therapy, in patients with advanced mesothelin-expressing cancer…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB
Sun Yat-sen University is recruiting a study to explore personalized treatment for patients with recurrent gynecologic cancers guided by MTB…